Emma K. Lendy

Statistics

Publications

Citations

1.8K

H-Index

Active since

2015

Affiliations

Purdue University West Lafayette(Current)

National Cancer Institute

Kumamoto University

National Center for Global Health and Medicine

California Institute for Biomedical Research

Emma K. Lendy is an author at Purdue University West Lafayette specializing in pharmacology, antiviral structure-activity relationships, and drug discovery.

ORCID

Publications per year

2015–2024

Publications

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Laura Riva, Shuofeng Yuan, Xin Yin et al. · Nature · 2020 · 856 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 296 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi et al. · Nature Communications · 2021 · 192 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 159 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies

Arun K. Ghosh, Jakka Raghavaiah, Dana Shahabi et al. · Journal of Medicinal Chemistry · 2021 · 90 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 11